Request an Appointment:
Online or Call 1-888-824-0200

Endocrine Genetics Clinic

VHL clinic

The University of Chicago Medicine Endocrine Genetics Clinic is a collaboration between the Comprehensive Cancer Risk and Prevention Clinic and the Endocrine Surgery Clinic. Our team includes a certified genetic counselor and endocrine surgery experts that work together to offer comprehensive risk assessment to patients with suspected inherited endocrine tumor syndromes. Patients meet with the genetic counselor to review family medical history and to discuss options for genetic testing. A board-certified endocrine surgeon provides recommendations for disease management.

The Endocrine Genetics Clinic welcomes individuals and families with one or more of the following endocrine disorders for consultation:

  • Adrenocortical carcinoma (before age 40)
  • Familial non-medullary thyroid cancer
    • Any patient who has one or more relatives with papillary or follicular thyroid cancer
    • Any patient under age 18 diagnosed with papillary or follicular thyroid cancer
  • Foregut carcinoids (bronchial, thymic, gastric)
  • Medullary thyroid cancer (any age)
  • Multifocal pancreatic neuroendocrine tumors
  • Multiglandular primary hyperparathyroidism (before age 40)
  • Paragangliomas (any age)
  • Parathyroid carcinoma
  • Pheochromocytomas
    • Any patient diagnosed before age 40
    • Malignant or multiple
  • Pituitary tumors (before age 25)
  • Two primary malignancies in the same individual, such as:
    • Thyroid and breast
    • Thyroid and endometrial
    • Thyroid and renal cell carcinoma (RCC)
    • RCC and breast 


Examples of common syndromes seen in the Endocrine Genetics Clinic include:

  • Multiple endocrine neoplasia type 1 (MEN1): parathyroid, pituitary, pancreas tumors
  • Multiple endocrine neoplasia type 2 (MEN2): medullary thyroid cancer; parathyroid, 
adrenal tumors
  • Hereditary pheochromocytoma/paraganglioma syndrome: pheo/paraganglioma; kidney 
cancer, gastrointestinal stromal tumor (GIST)
  • Von Hippel-Lindau syndrome (VHL): kidney cancer; brain, spine, adrenal, pancreatic 
tumors
  • Others, including: Cowden syndrome, neurofibromatosis type 1, Jaw tumor-hyperparathyroidism syndrome, familial hyperparathyroidism, Carney complex

Endocrine Genetics Team

Endocrine Surgery
Peter Angelos, MD, PhD
Raymon Grogan, MD
Edwin Kaplan, MD

Genetics
Sarah Nielsen, MS, CGC


Request an Appointment

Contact Us

For more information, call Felicia Steverson, Cancer Risk Administrative Coordinator, at (773) 702-1093.